BI 201335
1220.7
Phase 3 small_molecule completed
Quick answer
BI 201335 for Hepatitis C, Chronic is a Phase 3 program (small_molecule) at Boehringer Ingelheim with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim
- Indication
- Hepatitis C, Chronic
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed